A global drug company which pioneered the Covid vaccine has been victim of a cyber attack, Metro can reveal. AstraZeneca was ...

AstraZeneca’s chronic obstructive pulmonary disease (COPD) candidate has served up a third phase 3 win this year, offering ...

At the recent Society of Gynecologic Oncology annual meeting in Philadelphia, GSK (GSK) took the unusual step of unveiling ...

FRANKFURT, April 21 (Reuters) - AstraZeneca's CEO told daily Handelsblatt on Tuesday that Germany risks missing out on new ...

April 21 (Reuters) - AstraZeneca said on Tuesday its rare blood disorder drug Ultomiris has met the main goal of a late-stage ...

Speaking to German newspaper Handelsblatt, CEO Pascal Soriot said proposed cost-cutting measures in the country’s healthcare ...

A positive phase three trial result in a hard-to-treat cancer adds fresh momentum to one of AstraZeneca's most important growth drivers. Liver cancer is one of the most difficult cancers to treat, and ...

AstraZeneca has rolled out a fresh TV spot for its blockbuster-to-be Breztri, hitting the message that the product frees chronic obstructive pulmonary disease (COPD) patients to leave their bad days ...

AstraZeneca said on Monday its ‌experimental treatment tozorakimab showed a "meaningful reduction" in moderate-to-severe ...

After another swing and a miss for AstraZeneca's Fasenra in chronic obstructive pulmonary disease (COPD), the company is pivoting to other options in its portfolio that might have potential to treat ...

Ultomiris has met its primary endpoint in a phase III trial targeting immunoglobulin A nephropathy (IgAN), a rare ...

A federal appellate court has handed down the first appellate-level decision addressing the merits of drug manufacturers’ challenges to the Inflation Reduction Act of 2022's (IRA) Medicare Drug ...